The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Biomedica Share News (OXB)

Share Price Information for Oxford Biomedica (OXB)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 315.00
Bid: 315.50
Ask: 317.00
Change: -5.00 (-1.56%)
Spread: 1.50 (0.475%)
Open: 327.00
High: 329.50
Low: 315.00
Prev. Close: 320.00
OXB Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BROKER RATINGS: BoA likes Dowlais; JPMorgan cuts Phoenix Group

Fri, 22nd Sep 2023 09:33

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

----------

FTSE 100

----------

UBS raises Next price target to 7,250 (6,850) pence - 'neutral'

----------

SocGen raises Next price target to 8,287 (8,239) pence - 'buy'

----------

JPMorgan raises Next price target to 7,500 (7,300) pence - 'neutral'

----------

JPMorgan raises Next price target to 7,500 (7,300) pence - 'neutral'

----------

Goldman Sachs cuts SSE price target to 2,390 (2,431) pence - 'buy'

----------

JPMorgan raises M&G price target to 195 (180) pence - 'underweight'

----------

JPMorgan raises Admiral Group price target to 1,700 (1,650) pence - 'underweight'

----------

JPMorgan cuts Phoenix Group to 'underweight' (neutral) - price target 500 (655) pence

----------

JPMorgan cuts Prudential price target to 1,500 (1,630) pence - 'overweight'

----------

JPMorgan cuts Legal & General price target to 290 (315) pence - 'overweight'

----------

RBC raises Hargreaves Lansdown target to 900 (875) pence - 'sector perform'

----------

Deutsche Bank cuts Lloyds Banking price target to 62 (63) pence - 'buy'

----------

Deutsche Bank cuts Barclays price target to 200 (230) pence - 'hold'

----------

Deutsche Bank cuts NatWest price target to 320 (370) pence - 'buy'

----------

JPMorgan raises BP price target to 600 (530) pence - 'neutral'

----------

JPMorgan raises Shell price target to 3,200 (2,750) pence - 'overweight'

----------

FTSE 250

----------

Bank of America starts Dowlais with 'buy' - price target 144 pence

----------

Jefferies cuts Victrex price target to 1,420 (1,590) pence - 'hold'

----------

JPMorgan raises Hiscox to 'overweight' (neutral) - price target 1,300 (1,200) pence

----------

JPMorgan raises Just Group price target to 125 (120) pence - 'overweight'

----------

JPMorgan cuts Lancashire to 'neutral' (overweight) - price target 715 (750) pence

----------

Berenberg cuts Mobico Group price target to 140 (220) pence - 'buy'

----------

Deutsche Bank cuts Dunelm price target to 1,310 (1,340) pence - 'buy'

----------

Deutsche Bank cuts Virgin Money UK target to 210 (220) pence - 'hold'

----------

SMALL CAP

----------

Berenberg raises DFS Furniture price target to 185 (155) pence - 'buy'

----------

JPMorgan cuts Oxford BioMedica price target to 325 (495) pence - 'neutral'

----------

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
16 Apr 2021 09:49

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

BROKER RATINGS: RBC upgrades WH Smith and downgrades Dixons Carphone

Read more
15 Apr 2021 09:02

Oxford Biomedica swings to EBITDA profit

(Sharecast News) - Oxford Biomedica reported a 37% improvement in total revenues in its preliminary results on Thursday, to £87.7m.

Read more
15 Apr 2021 09:00

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Oxford BioMedica annual revenue leaps on AstraZeneca vaccine deal

Read more
8 Apr 2021 16:05

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
6 Apr 2021 08:19

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Oxford Biomedica signs viral vectors pact with Boehringer Ingelheim

Read more
6 Apr 2021 08:08

Oxford Biomedica strikes three-year deal with Boehringer Ingelheim

(Sharecast News) - Gene and cell therapy company Oxford Biomedica has signed a new three-year development and supply agreement with Boehringer Ingelheim, it announced on Tuesday, for the manufacture and supply of various types of viral vectors.

Read more
6 Apr 2021 07:53

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

LONDON MARKET PRE-OPEN: Returns in store for BP shareholders

Read more
21 Mar 2021 20:57

EU rebuffs UK calls to ship AstraZeneca COVID vaccines from Europe

By Francesco GuarascioBRUSSELS, March 21 (Reuters) - The European Union is rebuffing British government calls to ship AstraZeneca COVID-19 vaccines produced in a factory in the Netherlands, an EU official said on Sunday.Former EU member Britain ha...

Read more
19 Mar 2021 10:29

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Sanofi to terminate haemophilia development pact with Oxford Biomedica

Read more
19 Mar 2021 07:50

Oxford Biomedica says Sanofi pulling out of haemophilia project

(Sharecast News) - Oxford Biomedica said that Sanofi's decision to terminate collaboration on a haemophilia treatment would have a "negligible" impact on revenue.

Read more
3 Feb 2021 13:56

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

IN BRIEF: Oxford Biomedica Adds Genetics Professor To Non-Exec Team

Read more
29 Jan 2021 09:11

UPDATE 1-EU holds out for more after AstraZeneca offered 8 mln extra COVID-19 shots

* Astra had committed to at least 80 mln shots in Q1* EU funded two UK plants under deal with Astra - sources* Astra says UK has priority for doses produced there (Adds detail, background)By Francesco Guarascio and Sabine SieboldBRUSSELS, Jan 29 (Re...

Read more
18 Jan 2021 17:18

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

IN BRIEF: Oxford Biomedica's Facility In Oxford Now Formally Opened

Read more
8 Jan 2021 09:40

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

UK BROKER RATINGS SUMMARY: Shore Says Buy Hargreaves; UBS Cuts Next

Read more
8 Dec 2020 12:31

UK's initial AstraZeneca shots will come from Europe, taskforce says

By Alistair SmoutLONDON, Dec 8 (Reuters) - Britain's initial doses of the COVID-19 vaccine candidate developed by AstraZeneca and Oxford University will come from Europe rather than a domestic supply chain, the country's Vaccine Taskforce said.The...

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.